Help us amplify vital stories and drive change in underreported crises.

Support our work.
  1. Home
  2. Africa
  3. Southern Africa

AIDS drug stumbling block to upcoming trade talks

Intellectual property rights to urgently needed AIDS drugs remain a stumbling block as the Southern African Customs Union (SACU) prepares to revive free trade talks with the US in the next two weeks, analysts have said. Trade talks in Atlanta, US, collapsed last year partly as a result of disagreements over the drugs, with SACU pushing for the right to manufacture more generic versions of the medicines. Tenu Avafia, a senior researcher at the Trade Law Centre for Southern Africa, said the US position was "very restrictive" because generic pharmaceutical manufacturers had to wait five years before they could use the technology of US patent holders. "This could delay access to affordable antiretroviral medicines in SACU countries as the region battles the world's worst HIV/AIDS pandemic and widespread poverty," Avafia told Reuters.

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join